Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma;La transition épithéliomésenchymateuse au cours du développement dans la fibrose et dans la progression tumorale

Bulletin du Cancer

Volumn 97, Issue 11, 2010, Pages 1285-1295

  Thiery, J P ^a,b   Chua, K ^b   Sim, Wen Jing ^a   Huang, R ^a,b,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Carcinoma; Epithelium; Gastrulation; Invasion; Mesenchyme; Metastasis; Organogenesis; Targeted therapies

Indexed keywords

BIOLOGICAL FACTOR;

CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CARCINOMA; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; EVOLUTION; FIBROSIS; GASTRULATION; GERM LAYER; HIGH THROUGHPUT SCREENING; HUMAN; METASTASIS; NONHUMAN; REVIEW;

EID: 78650163548     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1206     Document Type: Review

References (43)

1. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol 2009 ; 21 : 708-16.
2. Sonnenberg A, Watt FM. Integrin special issue. J Cell Sci 2009 ; 122 : 157.
3. Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B. Functional atlas of the integrin adhesome. Nat Cell Biol 2007 ; 9 : 858-67.
4. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009 ; 139 : 871-90.
5. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009 ; 119 : 1420-8.
6. Oliveri P, Tu Q, Davidson EH. Global regulatory logic for specification of an embryonic cell lineage. Proc Natl Acad Sci USA 2008 ; 105 : 5955-62. (Pubitemid 351758381)
7. Bertocchini F, Stern CD. The hypoblast of the chick embryo positions the primitive streak by antagonizing nodal signaling. Dev Cell 2002 ; 3 : 735-44. (Pubitemid 35339490)
8. Breau MA, Pietri T, Stemmler MP, Thiery JP, Weston JA. A non-neural epithelial domain of embryonic cranial neural folds gives rise to ectomesenchyme. Proc Natl Acad Sci USA 2008 ; 105 : 7750-5. (Pubitemid 351872710)
9. Sauka-Spengler T, Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol 2008 ; 9 : 557-68. (Pubitemid 351881841)
10. Chu YS, Eder O, Thomas WA, Simcha I, Pincet F, Ben-Ze'ev A, et al. Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains. J Biol Chem 2006 ; 281 : 2901-10. (Pubitemid 43845756)
11. Broders-Bondon F, Chesneau A, Romero-Oliva F, Mazabraud A, Mayor R, Thiery JP. Regulation of XSnail2 expression by Rho GTPases. Dev Dyn 2007 ; 236 : 2555-66. (Pubitemid 47450945)
12. Perez-Alcala S, Nieto MA, Barbas JA. LSox5 regulates RhoB expression in the neural tube and promotes generation of the neural crest. Development 2004 ; 131 : 4455-65. (Pubitemid 39409687)
13. Smolen GA, Schott BJ, Stewart RA, Diederichs S, Muir B, Provencher HL, et al. A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev 2007 ; 21 : 2131-6. (Pubitemid 47360835)
14. Nakaya Y, Kuroda S, Katagiri YT, Kaibuchi K, Takahashi Y. Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. Dev Cell 2004 ; 7 : 425-38. (Pubitemid 39232977)
15. Maina F, Panté G, Helmbacher F, et al. Coupling MET to specific pathways results in distinct developmental outcomes. Mol Cell 2001 ; 7 : 1293-306. (Pubitemid 32607362)
16. Zhan Y, Fujino A, MacLaughlin DT, Manganaro TF, Szotek PP, Arango NA, et al. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 2006 ; 133 : 2359-69. (Pubitemid 44044557)
17. Nakajima Y, Yamagishi T, Hokari S, Nakamura H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec 2000 ; 258 : 119-27. (Pubitemid 30082904)
18. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez- Pomares JM, Diez J, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004 ; 18 : 99-115. (Pubitemid 38090691)
19. Fischer A, Steidl C, Wagner TU, Lang E, Jakob PM, Friedl P, et al. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 2007 ; 100 : 856-63. (Pubitemid 46555691)
20. Rivera-Feliciano J, Lee KH, Kong SW, Rajagopal S, Ma Q, Springer Z, et al. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006 ; 133 : 3607-18. (Pubitemid 44614283)
21. Arnoux V, Nassour M, L'Helgoualc'h A, Hipskind RA, Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 2008 ; 19 : 4738-49.
22. Ahmed N, Thompson EW, Quinn MA. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 2007 ; 213 : 581-8. (Pubitemid 350058249)
23. Lepilina A, Coon AN, Kikuchi K, Holdway JE, Roberts RW, Burns CG, et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006 ; 127 : 607-19. (Pubitemid 44647426)
24. Neilson EG. Mechanisms of disease: fibroblasts - a new look at an old problem. Nat Clin Pract Nephrol 2006 ; 2 : 101-8. (Pubitemid 43355218)
25. Scholten D, Osterreicher CH, Scholten A, Iwaisako K, Gu G, Brenner DA, et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in Mice. Gastroenterology 2010 (sous presse).
26. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008 ; 13 : 58-68. (Pubitemid 350309740)
27. Thiery JP. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002 ; 2 : 442-54.
28. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumor progression. Nat Rev Cancer 2005 ; 5 : 744-9. (Pubitemid 41486367)
29. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009 ; 6 : 339-51.
30. Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, et al. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Clin Cancer Res 2008 ; 14 : 3306-11.
31. Condeelis J, Segall JE. Intravital imaging of cell movement in tumors. Nat Rev Cancer 2003 ; 3 : 921-30. (Pubitemid 37500177)
32. Robinson BD, Jones JG. Tumor microenvironment of metastasis (TMEM): a novel tissue-based assay for metastatic risk in breast cancer. Future Oncol 2009 ; 5 : 919-21.
33. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009 ; 11 : 1287-96.
34. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008 ; 68 : 989-97. (Pubitemid 351272216)
35. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009 ; 69 : 4116-24.
36. Choi YL, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, et al. LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Res 2010 ; 70 : 2296-306.
37. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010 ; 17 : 98-110.
38. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008 ; 14 : 79-89. (Pubitemid 351890463)
39. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009 ; 15 : 195-206.
40. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 ; 133 : 704-15. (Pubitemid 351636299)
41. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010 ; 28 : 341-7.
42. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010 ; 12 : 247-56.
43. Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D, et al. Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 2007 ; 6 : 532-41. (Pubitemid 46332455)